SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-002279
Filing Date
2021-10-25
Accepted
2021-10-25 16:36:09
Documents
14
Period of Report
2021-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20211019.htm   iXBRL 8-K 58406
2 EX-10.1 acet-ex10_1.htm EX-10.1 107582
3 EX-10.2 acet-ex10_2.htm EX-10.2 57890
  Complete submission text file 0000950170-21-002279.txt   377825

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20211019.xsd EX-101.SCH 2495
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20211019_lab.xml EX-101.LAB 19138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20211019_pre.xml EX-101.PRE 11504
7 EXTRACTED XBRL INSTANCE DOCUMENT acet-20211019_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211344550
SIC: 2834 Pharmaceutical Preparations